Predicting remission after internet-delivered psychotherapy in patients with depression using machine learning and multi-modal data.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 12 05 2021
accepted: 22 08 2022
revised: 17 08 2022
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

This study applied supervised machine learning with multi-modal data to predict remission of major depressive disorder (MDD) after psychotherapy. Genotyped adult patients (n = 894, 65.5% women, age 18-75 years) diagnosed with mild-to-moderate MDD and treated with guided Internet-based Cognitive Behaviour Therapy (ICBT) at the Internet Psychiatry Clinic in Stockholm were included (2008-2016). Predictor types were demographic, clinical, process (e.g., time to complete online questionnaires), and genetic (polygenic risk scores). Outcome was remission status post ICBT (cut-off ≤10 on MADRS-S). Data were split into train (60%) and validation (40%) given ICBT start date. Predictor selection employed human expertise followed by recursive feature elimination. Model derivation was internally validated through cross-validation. The final random forest model was externally validated against a (i) null, (ii) logit, (iii) XGBoost, and (iv) blended meta-ensemble model on the hold-out validation set. Feature selection retained 45 predictors representing all four predictor types. With unseen validation data, the final random forest model proved reasonably accurate at classifying post ICBT remission (Accuracy 0.656 [0.604, 0.705], P vs null model = 0.004; AUC 0.687 [0.631, 0.743]), slightly better vs logit (bootstrap D = 1.730, P = 0.084) but not vs XGBoost (D = 0.463, P = 0.643). Transparency analysis showed model usage of all predictor types at both the group and individual patient level. A new, multi-modal classifier for predicting MDD remission status after ICBT treatment in routine psychiatric care was derived and empirically validated. The multi-modal approach to predicting remission may inform tailored treatment, and deserves further investigation to attain clinical usefulness.

Identifiants

pubmed: 36050305
doi: 10.1038/s41398-022-02133-3
pii: 10.1038/s41398-022-02133-3
pmc: PMC9437007
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

357

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH110427
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

BMC Med Inform Decis Mak. 2016 Jul 25;16 Suppl 3:74
pubmed: 27454392
J Med Internet Res. 2018 Oct 10;20(10):e10754
pubmed: 30305255
Front Psychol. 2019 Mar 29;10:589
pubmed: 30984061
Ann Intern Med. 2019 Jan 1;170(1):W1-W33
pubmed: 30596876
J Psychiatr Res. 2004 Nov-Dec;38(6):577-82
pubmed: 15458853
Science. 1989 Mar 31;243(4899):1668-74
pubmed: 2648573
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
PLoS One. 2014 Jun 24;9(6):e100614
pubmed: 24959666
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
Mol Psychiatry. 2019 Apr;24(4):484-490
pubmed: 30410065
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
J Anxiety Disord. 2018 Mar;54:24-32
pubmed: 29421369
Harv Rev Psychiatry. 2017 May/Jun;25(3):114-122
pubmed: 28475503
Prim Care Companion CNS Disord. 2015 Jun 25;17(3):
pubmed: 26644958
Cognit Ther Res. 2019 Jun;43(3):620-630
pubmed: 32879540
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64
pubmed: 23252357
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
World Psychiatry. 2021 Jun;20(2):154-170
pubmed: 34002503
J Consult Clin Psychol. 2020 Apr;88(4):311-321
pubmed: 31829635
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Am J Psychiatry. 2019 Apr 1;176(4):315-323
pubmed: 30696270
Front Psychiatry. 2019 Oct 25;10:749
pubmed: 31708813
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
J Affect Disord. 2001 May;64(2-3):203-16
pubmed: 11313087
Neuropsychopharmacology. 2021 Jan;46(1):176-190
pubmed: 32668442
Internet Interv. 2019 Jan 31;15:116-125
pubmed: 30792963
Science. 2015 Jul 17;349(6245):255-60
pubmed: 26185243
Transl Psychiatry. 2019 May 23;9(1):150
pubmed: 31123309
J Affect Disord. 2014 Feb;155:49-58
pubmed: 24238951
Behav Res Ther. 2021 Jan;136:103767
pubmed: 33249272

Auteurs

John Wallert (J)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden. john.wallert@ki.se.

Julia Boberg (J)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

Viktor Kaldo (V)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.
Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, Växjö, Sweden.

David Mataix-Cols (D)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.
CAP Research Centre, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Oskar Flygare (O)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

James J Crowley (JJ)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

Matthew Halvorsen (M)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

Fehmi Ben Abdesslem (F)

Research Institutes of Sweden, Kista, Sweden & Royal Institute of Technology, Stockholm, Sweden.

Magnus Boman (M)

Research Institutes of Sweden, Kista, Sweden & Royal Institute of Technology, Stockholm, Sweden.
Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Solna, Sweden.

Evelyn Andersson (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

Nils Hentati Isacsson (N)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

Ekaterina Ivanova (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

Christian Rück (C)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm HealthCare Services, Region Stockholm, Huddinge, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH